Gabelli & Co Investment Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-307,358	Closed	-$15.9M	–	461
2022 Q3	$15.9M	Buy	+307,358	New	+$12.7M	2.06%	9

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's CCXI Position: Q4 2022 in Review

Gabelli & Co Investment Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 307,358 shares — an estimated $15.9M sold.

Gabelli & Co Investment Advisers first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $15.9M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Gabelli & Co Investment Advisers reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 307,358 ChemoCentryx, Inc. shares in Q4 2022, an estimated $15.9M.
Gabelli & Co Investment Advisers first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Gabelli & Co Investment Advisers's ChemoCentryx, Inc. position peaked at $15.9M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.